A fertilized egg somehow manages to build skin, brain, and blood cells within days. But how? New tech called LoxCode is helping us find out.

Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell ...

FDA updates CAR T-cell therapy labels for liso-cel and ide-cel, easing monitoring requirements and expanding access for ...

B ristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has given approval to label updates ...

Human cells are able to respond to applied electrical signals and their response is different according to cell health status. In this framework, the electrical bio-impedance can be sensitive tools to ...

In this open-label, multicentre, randomised controlled trial conducted in China, patients with CLDN18.2-positive (immunohistochemistry expression intensity ≥2+ and positive tumour cells ≥40%) advanced ...

Engineering three-dimensional (3D) scaffolds with in vivo like architecture and function has shown great potential for tissue regeneration. Here we developed a facile microfluidic-based strategy for ...

Results: All 4T1 cells treated with various concentrations of Ac4ManNAz and DBCO-Cy5.5 showed positive fluorescent signals, and the fluorescence intensity increased with the concentration of Ac4ManNAz ...

Small-cell lung cancer (SCLC) is an aggressive malignancy with limited treatments. Delta-like ligand 3 (DLL3) is aberrantly expressed in most SCLC. Tarlatamab (AMG 757), a bispecific T-cell engager ...